Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Sales (2020 - 2025)

Maravai Lifesciences Holdings has reported Return on Sales over the past 6 years, most recently at 1.26% for Q4 2025.

  • Quarterly results put Return on Sales at 1.26% for Q4 2025, down 45.0% from a year ago — trailing twelve months through Dec 2025 was 1.24% (down 24.0% YoY), and the annual figure for FY2025 was 1.24%, down 24.0%.
  • Return on Sales for Q4 2025 was 1.26% at Maravai Lifesciences Holdings, down from 1.08% in the prior quarter.
  • Over the last five years, Return on Sales for MRVI hit a ceiling of 0.65% in Q2 2022 and a floor of 2.5% in Q3 2024.
  • Median Return on Sales over the past 5 years was 0.2% (2023), compared with a mean of 0.31%.
  • Biggest five-year swings in Return on Sales: crashed -227bps in 2024 and later skyrocketed 142bps in 2025.
  • Maravai Lifesciences Holdings' Return on Sales stood at 0.56% in 2021, then decreased by -23bps to 0.43% in 2022, then crashed by -447bps to 1.48% in 2023, then soared by 45bps to 0.81% in 2024, then crashed by -55bps to 1.26% in 2025.
  • The last three reported values for Return on Sales were 1.26% (Q4 2025), 1.08% (Q3 2025), and 1.47% (Q2 2025) per Business Quant data.